[IEEE-bhpjobs] Jan 17 AAPS NC Pharma Discussion Group and PDA-SE Joint Symposium

Fri Dec 29 23:33:19 EST 2006

-------- Original Message --------
Date: 	Wed, 27 Dec 2006 16:50:34 -0500 (EST)
From: 	PDA Southeast Chapter <dwilliamsinc at bellsouth.net>
Reply-To: 	dwilliamsinc at bellsouth.net

Joint Symposium
January 17 (Wednesday), 11:30 am – 2:00 pm

*The North Carolina Pharmaceutical Discussion Group (NCPDG) of the
American Association of Pharmaceutical Scientists (AAPS) and the
Parenteral Drug Association - Southeast Chapter (PDASE) Sponsor a Joint
Symposium:*

*

     * Two Topics:

* */1. Scientific Approaches to Rapid Early Phase Formulation Development/*
Kwok Chow, Ph.D., Sr. Director of Pharmaceutics Technologies
Patheon Inc., Mississauga, Ontario, Canada

*2. Technology Transfer for Fast to Market Drug Products*
Gary W. Goodson, Manager of Product Development
GlaxoSmithKline, Research Triangle Park, North Carolina

*

     * Where:

* Congressional Room North Carolina Biotechnology Center Research
Triangle Park 15 T.W. Alexander Dr, Research Triangle Park, NC 27709
1-919-541-9366

*

     * When:

* January 17 (Wednesday), 11:30 am – 2:00 pm

*

     * Agenda:

* On-site payment and lunch start at 11:30 am; the 1st presentation
begins at 12:00 noon and the 2nd presentation begins at 1:00 pm.

*Must RSVP by January 10 (Wednesday), 2007 *by emailing back the
completed registration form and dietary restrictions (e.g. vegetarian
meal) to ppande at rti.org <mailto:ppande at rti.org>

Space is limited to the first 100 registrants. Please forward your
payment while sending your email for registration to secure your seat.
We will not accept any cancellations after January 10, but you are
expected to make the payment as the meals are ordered based on your
registration.

*Make Checks Payable to:*
NCPDG

Mail to: or Pay check/cash at the door.
Dr. Poonam Pande
303 Perry Creek Dr.
Chapel Hill NC 27514

*_Registration Form_*
Name:
Title:
Affiliation (Company/School):
Phone:
Email:

*Registration Fee (includes lunch and presentation)*
___$25 general
___$15 for full-time university students (must show student I.D. at
registration)

*Scientific Approaches to Rapid Early Phase Formulation Development* *
Kwok Chow, Ph.D.*
Patheon Inc, Mississauga, Ontario, Canada

*Abstract *
Speed to clinic is a critical requirement for development of NCEs
especially at an early phase of the program. It is important to develop
the clinical formulation quickly without compromising the clinical goal,
budget and quality of the product. This presentation will discuss the
objectives in early formulation development. An introduction of the use
of preformulation and biopharmaceutics data on the development of
formulation strategies, including the choice of formulations, will be
provided. A tool box approach comprising the use of simplified
formulations, statistical design of experiment, nanotechnologies, use of
miniaturized equipment and processes, and integrated analytical
development approach will also be presented. Examples together with
success factors will be used to demonstrate ‘quick to clinic’
formulation development in early clinical programs. *

Biography*
Dr. Kwok Chow is the Senior Director of Pharmaceutics Technologies at
Patheon Inc. Previously, he was the Director of Formulation Development
(also at Patheon) managing the formulation development group since
February 2001.

Dr. Chow received his B.S. in Pharmacy from the University of Minnesota
and Ph.D. in Industrial Pharmacy from the University of Toronto with
Professor David Grant. He began his formulation development career at
Glaxo and was leading the development of conventional and novel dosage
forms including tablets, capsules, liquids, suspensions, nasal sprays,
powder for reconstitution and fast dissolving formulations. Dr. Chow has
successfully supported the introduction of new chemical entities and
line extension products in North America, Europe, Japan and Asian
Pacific countries. He is also a specialist in solid-state pharmaceutics
and powder technology. He is the author or co-author of a number of
patents, research articles and abstracts.

*Technology Transfer for Fast to Market Drug Products* *
Gary W. Goodson*
GlaxoSmithKline, Research Triangle Park, North Carolina

*Biography*
Gary Goodson is the Manager of Product Development in Pharmaceutical
Development at GlaxoSmithKline. His responsibilities include formulation
development, process optimization, scale- up and transfer of NCEs and
product line extensions. He received his B.S. in Biology from Radford
University in 1978. From 1978 to 1987, he held several scientific
positions with SmithKline Beecham where he was involved in the
formulation such as development of Augmentin® ; Oral Suspension, Relafen
® ; Tablets and Paxil® ; Tablets. In 1987 he joined Glaxo as a scientist
in the Pharmaceutics Department where he was responsible for the design
of Glaxo’s formulation development laboratories and Pilot Plant. He has
served on numerous development project teams including Ventolin® ;
Inhalers, Epivir® ; Tablets, Combivir® ; Tablets and Ziagen® ; Tablets,
Trizivir® ; Tablets, Imitrex® ; Tablets and Kivexa Tablets. He was a key
driver in establishing a global secondary technology transfer process
for Glaxo Wellcome and for GlaxoSmithKline. He currently leads two
international development teams for Metabolic and Migraine Products
where his responsibilities span from candidate selection through
commercial product launch.

He currently leads two international development teams for Metabolic and
Migraine Products where his responsibilities span from candidate
selection through commercial product launch.

------------------------------------------------------------------------
dwilliamsinc at bellsouth.net <mailto:dwilliamsinc at bellsouth.net>

<http://ui.constantcontact.com/d.jsp?p=un&m=1101201447149&ea=esther_l%40ieee.org&se=1711&t=1101492152798&lang=en&reason=F> 

This email was sent to esther_l at ieee.org, by dwilliamsinc at bellsouth.net
<mailto:dwilliamsinc at bellsouth.net>
Update Profile/Email Address
<http://ui.constantcontact.com/d.jsp?p=oo&m=1101201447149&ea=esther_l%40ieee.org&se=1711&t=1101492152798&lang=en&reason=F> 

| Instant removal with SafeUnsubscribe
<http://ui.constantcontact.com/d.jsp?p=un&m=1101201447149&ea=esther_l%40ieee.org&se=1711&t=1101492152798&lang=en&reason=F>™ 

| Privacy Policy <http://ui.constantcontact.com/roving/CCPrivacyPolicy.jsp>.

Powered by
<http://www.constantcontact.com/index.jsp?cc=cards01>

PDA SE | 302 Versailles Dr. | Cary | NC | 27511

-- 
-- Esther L., esther_L (at) ieee.org, Speaking only for myself.
If your email to me bounces, check the _L and the H in esther.
-------------- next part --------------
An embedded and charset-unspecified text was scrubbed...
Name: file:///C|/DOCUME%7E1/ESTHER/LOCALS%7E1/TEMP/nsmail.txt
Url: http://rtpnet.org/pipermail/ieee-bhpjobs/attachments/20061229/5301dbae/attachment.txt 